MUPIROCIN | A065123 | PADAGIS ISRAEL PHARMACEUTICALS LTD
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Encube Ethicals Private Limited FDA-2018-P-1516 · 3 docket documents Encube Ethicals Private Limited filed this citizen petition on April 13, 2018, requesting that the FDA designate ANDA 201587 held by Glenmark Pharmaceuticals Inc USA as a reference standard for Mupirocin Calcium Cream, EQ 2% Base, because the currently designated reference listed drug and reference | 505(q) | 2018-04-16 | Open | Encube Ethicals Private Limited |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.2921
per gm
Lowest NADAC/Unit
$0.1362
per gm
Brand NDCs
0
Generic NDCs
2
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 45802011214MUPIROCIN 2% OINTMENT | $0.2921 | GM | Generic | — | 2026-06-17 |
| 45802011222MUPIROCIN 2% OINTMENT | $0.1362 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.